Abstract:Inflammatory bowel disease (IBD) increases the risk of colorectal cancer, and it has the potential to diminish the quality of life. Clinical and experimental evidence demonstrate protective aspects of parasitic helminth infection against IBD. However, studies on the inhibition of inflammation by helminth infection have overlooked a key determinant of health: the gut microbiota. Although infection with helminths induces alterations in the host microbiota composition, the potential influence and mechanism of helminth infections induced changes in the gut microbiota on the development of IBD has not yet been elucidated. In this study, we analyzed the intersection of helminth Trichinella spiralis and gut bacteria in the regulation of colitis and related mechanisms. T . spiralis infected mice were treated with antibiotics or cohoused with wild type mice, then challenged with dextran sodium sulfate (DSS)-colitis and disease severity, immune responses and goblet cells assessed. Gut bacteria composition was assessed by 16S rRNA sequencing and short-chain fatty acids (SCFAs) were measured. We found that protection against disease by infection with T . spiralis was abrogated by antibiotic treatment, and cohousing with T . spiralis - infected mice suppressed DSS-colitis in wild type mice. Bacterial community profiling revealed an increase in the abundance of the bacterial genus Muribaculum and unclassified_Muribaculaceae in mice with T . spiralis infection or mice cohoused with T . spiralis - infected mice. Metabolomic analysis demonstrated significantly increased propionic acid in feces from T . spiralis - infected mice. Data also showed that the gut microbiome modulated by T . spiralis exhibited enhanced goblet cell differentiation and elevated IL-10 levels in mice. These findings identify the gut microbiome as a critical component of the anti- colitic effect of T . spiralis and gives beneficial insights into the processes by which helminth alleviates colitis. IBD encompasses Crohn's Disease and Ulcerative Colitis. It affects both children and adults. Reports have highlighted the potential use of helminths or their byproducts as a possible treatment for IBD. Accumulating evidence also suggests that the gut microbiota is a key factor in modulating IBD. In this study, we revealed the protective effect of a prior infection with T . spiralis on DSS- induced colitis in mice. Specifically, T . spiralis infection reshaped the gut microbiome of mice, resulting in an increased abundance of SCFA-producing bacteria Muribaculum and unclassified_Muribaculaceae and thereby producing a larger amount of propionic acid. Furthermore, the gut microbiome modulated by T . spiralis exhibited enhanced goblet cell differentiation and elevated IL-10 levels, ultimately ameliorating experimental colitis. These findings suggest that the modulation of host microbiota during T . spiralis infection plays a crucial role in the suppression of colitis, and any intention-to-treat with helminth therapy should be based on the patient's immunological and microbiological response to the helminth.

Protective effect of Schistosoma japonicum eggs on TNBS-induced colitis is associated with regulating Treg/Th17 balance and reprogramming glycolipid metabolism in mice

Schistosoma Japonicum Eggs Modulate the Activity of CD4+ CD25+ Tregs and Prevent Development of Colitis in Mice

Suppression of Schistosoma Japonicum Eggs on TNBS-induced Colitis in Mice

An insight into the gut microbiota after Schistosoma japonicum eggs immunization in an experimental ulcerative colitis model

Therapeutic Potential of Recombinant Cystatin from Schistosoma Japonicum in TNBS-induced Experimental Colitis of Mice.

Schistosoma Japonicum Attenuates Dextran Sodium Sulfate-Induced Colitis in Mice Via Reduction of Endoplasmic Reticulum Stress

Monosexual Cercariae of Schistosoma japonicum Infection Protects Against DSS-Induced Colitis by Shifting the Th1/Th2 Balance and Modulating the Gut Microbiota

Dietary Eggshell Membrane Powder Improves Survival Rate and Ameliorates Gut Dysbiosis in Interleukin-10 Knockout Mice

Gut Microbiota Modulates Intestinal Pathological Injury in Schistosoma japonicum-Infected Mice

Gut Microbiota Modulates Intestinal Pathological Injury in <i>Schistosoma japonicum</i>-Infected Mice

Schistosoma japonicum Infection Leads to the Reprogramming of Glucose and Lipid Metabolism in the Colon of Mice

Heat Shock Protein 60 in Eggs Specifically Induces Tregs and Reduces Liver Immunopathology in Mice with Schistosomiasis Japonica

The gut microbiota is essential for - evoked suppression of colitis

A Boswellic Acid-Containing Extract Ameliorates Schistosomiasis Liver Granuloma and Fibrosis Through Regulating NF-κB Signaling in Mice.

Recombinant protein Schistosoma japonicum -derived molecule attenuates dextran sulfate sodium-induced colitis by inhibiting miRNA-217-5p to alleviate apoptosis

rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway.

The Protective Effect of the Recombinant 53-kDa Protein of Trichinella spiralis on Experimental Colitis in Mice

Excretory/secretory Products from Trichinella Spiralis Adult Worms Ameliorate DSS-induced Colitis in Mice.

Immune Protection of a Helminth Protein in the DSS-Induced Colitis Model in Mice

Bacillus Subtilis Attenuates Hepatic and Intestinal Injuries and Modulates Gut Microbiota and Gene Expression Profiles in Mice Infected with Schistosoma Japonicum.

The gut microbiota is essential for Trichinella spiralis —Evoked suppression of colitis